文章核心观点 - 公司的病理学部门收入已经超过了盈亏平衡点,但由于一些运营问题导致收入下降,目前正在解决这些问题,预计下一个季度将重新超过盈亏平衡点 [2][3] - 公司产品部门由于一些技术和供应链问题导致产品发布延迟,但这些问题已经解决,收入增长正在恢复,并有两家大客户即将上线使用公司技术 [4][5] - 公司受到了Change Healthcare遭黑客攻击的影响,导致病理学服务部门现金流受阻,但公司已采取措施通过短期贷款补充现金流,预计在第三季度恢复正常运营 [6][7] - FDA最新的LDT(实验室自主研发检测)监管规定将对公司的病理学服务部门和产品部门产生影响,但公司已制定应对措施,预计不会对公司造成重大财务影响 [8][9][10][11][12][14][15][16] 文章其他要点 业务增长 - 公司病理学部门在2023年第四季度实现了盈亏平衡,现金消耗降至10万美元以下 [2] - 公司产品部门收入增长受到一些技术和供应链问题的影响,但这些问题已经解决,收入增长正在恢复,有两家大客户即将上线使用公司技术 [4][5] Change Healthcare黑客攻击及现金影响 - 公司受到Change Healthcare遭黑客攻击的影响,导致病理学服务部门现金流受阻,但公司已采取措施通过短期贷款补充现金流,预计在第三季度恢复正常运营 [6][7] - 随着收入增长,公司预计现金消耗将逐步减少,有望在今年晚些时候实现盈亏平衡 [7] FDA LDT监管规定 - FDA最新的LDT监管规定将要求实验室自主研发的检测产品进行FDA注册和审批,给公司的病理学服务部门和产品部门带来影响 [8][9] - 对于病理学服务部门,公司现有的检测产品无需额外工作即可"被纳入豁免",未来新增检测产品也可选择FDA批准的产品,不会对公司造成重大财务影响 [10][11][12] - 对于产品部门,公司选择由自身提交产品进行FDA审批,而不是要求客户实验室自行提交,这将为客户减轻负担,并为公司带来竞争优势 [14][15][16] - 公司预计FDA审批过程中的成本约为25万美元 [16]

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____ to _____ Commission File Number: 001-36439 PRECIPIO, INC. (Exact name of registrant as specified in its charter) Delaware 91-1789357 ( ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR ◻ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-36439 PRECIPIO, INC. (Exact name of registrant as specified in its charter) Delaware 91-1789357 (State or other ju ...

Precipio, Inc. (NASDAQ:PRPO) Q3 2023 Earnings Conference Call November 20, 2023 5:00 PM ET Company Participants Ilan Danieli - Chief Executive Officer Operator Welcome to the Precipio Third Quarter 2023 Shareholder Update Conference Call. All participants will be in listen-only mode. [Operator Instructions] Please note that the conference is being recorded. Statements made during this call contain forward-looking statements about our business. You should not place undue reliance on forward-looking statement ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____ to _____ Commission File Number: 001-36439 PRECIPIO, INC. (Exact name of registrant as specified in its charter) Delaware 91-17893 ...

Precipio, Inc. (NASDAQ:PRPO) Q2 2023 Earnings Conference Call August 17, 2023 5:00 PM ET Company Participants Ilan Danieli - CEO Conference Call Participants Operator Welcome to the Precipio Second Quarter 2023 Shareholder Update Conference Call. All participants will be in listen-only mode. [Operator Instructions] Please note that the conference is being recorded. Statements made during this call contain forward-looking statements about our business. You should not place undue reliance on forward-looking s ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____ to _____ Commission File Number: 001-36439 PRECIPIO, INC. (Exact name of registrant as specified in its charter) Delaware 91-1789357 (S ...

Precipio, Inc. (NASDAQ:PRPO) Q1 2023 Earnings Conference Call May 17, 2023 5:00 PM ET Company Participants Ilan Danieli - CEO Conference Call Participants Operator Welcome to the Precipio Q1 2023 Shareholder Update Conference Call. All participants will be in listen-only mode. [Operator Instructions] Please note that the conference is being recorded. Statements made during this call contain forward-looking statements about our business. You should not place undue reliance on forward-looking statements as th ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____ to _____ Commission File Number: 001-36439 PRECIPIO, INC. (Exact name of registrant as specified in its charter) Delaware 91-1789357 ( ...

Precipio, Inc. (NASDAQ:PRPO) Q4 2022 Earnings Conference Call April 3, 2023 5:00 PM ET Company Participants Ilan Danieli - CEO Operator Welcome to the Precipio Shareholder 2022 Fourth Quarter and Year-End Shareholder Update Conference Call. All participants will be in listen-only mode. [Operator Instructions] Please note that the conference is being recorded. Statements made during this call contain forward-looking statements about our business. You should not place undue reliance on forward-looking stateme ...